Vanguard has announced final amounts and the payment date for the next round of distributions for ASX ETF investors.

The ASX 200 stock revealed that year-to-date to February 2025, pathology volumes were up 4% while revenue increased by 6.2%, ...

The leading broker has picked out a number of ASX healthcare stocks that it thinks investors should be buying right ...

ASX listed gold miners have started the year on a strong note, bucking the trend of the wider ASX stock market.

These ASX ETFs could offer better yields than Commonwealth Bank of Australia (ASX: CBA) term deposits. Let's see ...

The iShares S&P 500 ETF (IVV) has a reputation for delivering capital growth. But, what about dividend yield from this ETF?

Artificial intelligence is helping ASX healthcare companies streamline analysis and diagnosis. Here are two leaders of the ...

As for income, the broker is forecasting dividends per share of 27 cents in FY 2025 and then 31 cents in FY 2026. Based on ...

Feeling nervous about market volatility? Check out these 2 ASX defensive stocks outside the traditional sectors.

But despite the headlines, one thing hasn't changed: long-term investing still works. And for ASX share investors, building a ...

The ASX 200 biotech stock notes that HIE is a devastating type of brain injury caused when a baby's brain does not receive ...

Up 48% in a year, this S&P/ASX 200 Index (ASX: XJO) dividend stock is well-placed to deliver reliable income and further ...